Pseudomonas Infections - 25 Studies Found Terminated : Lcr35 / ICU / P. Aeruginosa : Pseudomonas Infections : 2008-02-11 : Drug: Probiotic Lactobacillus casei rhamnosus (Lcr35) Completed : Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects : Pseudomonas Aeruginosa : 2016-02-11 : Drug: MEDI3902 Active Completed : Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol® in Healthy Subjects : Pseudomonas Infection : 2014-06-26 : Drug: Fosfomycin tromethamine Terminated : Azithromycin as a Quorum-Sensing Inhibitor for the Prevention of Pseudomonas Aeruginosa Ventilator-Associated Pneumonia : Pneumonia, Ventilator-Associated Pseudomonas Infections : 2008-01-24 : Drug: azithromycin 300 mg/day, Completed : Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas Aeruginosa : Pseudomonas Aeruginosa Infection : 2011-05-16 : Drug: Piperacillin-Tazobactam continuous infusion Recruiting : Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa : Pseudomonas Infection Cystic Fibrosis : 2001-11-27 Completed : The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis : Pseudomonas Aeruginosa Cystic Fibrosis : 2012-01-09 Completed : Nasal Inhalation of Tobramycin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization : Cystic Fibrosis Pseudomonas Aeruginosa : 2008-10-16 : Drug: Tobramycin (Gernebcin®) 1 ml / day in each nostril Completed : Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43 : Pseudomonas Aeruginosa Infection : 2012-03-14 : Biological: IC43 100 mcg Completed : Impact of the Contamination Mode on the Clinical Evolution During Pseudomonas Aeruginosa Ventilator Acquired Pneumonia (PYO GEN) : Pseudomonas Aeruginosa Ventilation Acquired Pneumonia : 2012-10-08 Next >>>
